Inventor · disambiguated record
Patrick J. Scannon
Also filed as: SCANNON PATRICK · SCANNON PATRICK J
31 granted patents·8 pending applications·712 citations·filing 1983–2025
97Inventor score
Top patents by PatentIndex Score
39 records- 0193US7695718B2Methods for the treatment of IL-1β related diseasesXOMA TECHNOLOGY LTD·Filed 2007·Granted Apr 13, 2010·19 cites·54 claims
- 0292US8584349B2Flexible manufacturing systemXOMA TECHNOLOGY LTD·Filed 2012·Granted Nov 19, 2013·41 cites·28 claims
- 0392US4473496AIntramolecularly crosslinked hemoglobinUS ARMY·Filed 1983·Granted Sep 25, 1984·90 cites·7 claims
- 0489US4925922APotentiation of cytotoxic conjugatesXOMA CORP·Filed 1989·Granted May 15, 1990·135 cites·8 claims
- 0587US4590071AHuman melanoma specific immunotoxinsXOMA CORP·Filed 1984·Granted May 20, 1986·79 cites·20 claims
- 0685US10294658B2Flexible manufacturing systemSCANNON PATRICK J·Filed 2009·Granted May 21, 2019·23 cites·36 claims
- 0785US4916213ARibosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereofXOMA CORP·Filed 1988·Granted Apr 10, 1990·103 cites·28 claims
- 0884US8377429B2Methods for improvement of beta cell function with anti-IL-1β antibodies or fragments thereofXOMA TECHNOLOGY LTD·Filed 2009·Granted Feb 19, 2013·5 cites·27 claims
- 0981US8101166B2Methods for the treatment of IL-1β related diseasesSOLINGER ALAN M·Filed 2010·Granted Jan 24, 2012·4 cites·92 claims
- 1079US4664913AMethod for treating plasma for transfusionXOMA CORP·Filed 1984·Granted May 12, 1987·56 cites·8 claims
- 1177US10611832B2Cardiovascular related uses of IL-1β antibodies and binding fragments thereofXOMA US LLC·Filed 2017·Granted Apr 7, 2020·1 cites·48 claims
- 1277US5643875AHuman therapeutic uses of bactericidal/permeability increasing (BPI) protein productsFiled 1994·Granted Jul 1, 1997·26 cites·12 claims
- 1374US5627153AAnti-fungal methods and materialsXOMA CORP·Filed 1995·Granted May 6, 1997·28 cites·16 claims
- 1473US9163082B2Methods for the treatment of IL-1β related diseasesXOMA US LLC·Filed 2013·Granted Oct 20, 2015·1 cites·51 claims
- 1573US5686414AMethods of treating conditions associated with corneal transplantationXOMA CORP·Filed 1995·Granted Nov 11, 1997·32 cites·9 claims
- 1672US6596691B2Therapeutic uses of BPI protein products for human meningococcemiaXOMA CORP·Filed 2000·Granted Jul 22, 2003·2 cites·4 claims
- 1769US6509317B1Method of treating chronic cardiac diseaseUNIV TEXAS·Filed 2000·Granted Jan 21, 2003·3 cites·10 claims
- 1867US12275974B2Synthetic enzyme complexes for in vitro rubber productionUS AGRICULTURE·Filed 2021·Granted Apr 15, 2025·0 cites·25 claims
- 1967US7045501B2Method of treating chronic cardiac diseaseXOMA TECHNOLOGY·Filed 2003·Granted May 16, 2006·1 cites·7 claims
- 2067US5756464ATherapeutic uses of BPI protein products in humans with hemmorhage due to traumaXOMA CORP·Filed 1997·Granted May 26, 1998·21 cites·5 claims
- 2165US8545846B2Methods for treating IL-1β related diseases by administering an anti-IL-1β antibodySCANNON PATRICK J·Filed 2009·Granted Oct 1, 2013·0 cites·21 claims
- 2264US6586400B2Human therapeutic uses of BPI protein productsXOMA CORP·Filed 2000·Granted Jul 1, 2003·1 cites·8 claims
- 2364US2006171937A1Method of treating chronic cardiac diseaseUNIV TEXAS·Filed 2006·Application pending·0 cites
- 2463US2025257370A1Synthetic enzyme complexes for in vitro rubber productionUS AGRICULTURE·Filed 2025·Application pending·0 cites
- 2562US5753620AHuman therapeutic uses of BPI protein productsXOMA CORP·Filed 1995·Granted May 19, 1998·13 cites·6 claims
- 2657US10106974B2Flexible manufacturing systemXOMA CORP·Filed 2016·Granted Oct 23, 2018·0 cites·13 claims
- 2757US2021009679A1Cardiovascular related uses of il-1beta antibodies and binding fragments thereofXOMA US LLC·Filed 2020·Application pending·0 cites
- 2856US5990086ATherapeutic uses of BPI protein products for human meningococcemiaXOMA CORP·Filed 1998·Granted Nov 23, 1999·6 cites·9 claims
- 2955US5888977ATherapeutic uses of BPI protein products for human meningococcemiaFiled 1997·Granted Mar 30, 1999·6 cites·4 claims
- 3055US2014017249A1Methods for improvement of beta cell functionXOMA TECHNOLOGY LTD·Filed 2013·Application pending·0 cites
- 3153US8586036B2Methods for the treatment of IL-1β related diseasesSOLINGER ALAN M·Filed 2010·Granted Nov 19, 2013·0 cites·56 claims
- 3250US5952302AHuman therapeutic uses of BPI protein productsXOMA CORP·Filed 1998·Granted Sep 14, 1999·6 cites·8 claims
- 3349US2003017986A1Methods of treating conditions associated with corneal injuryXOMA CORP·Filed 2002·Application pending·0 cites
- 3447US2002128191A1Methods of treating conditions associated with corneal injuryXOMA CORP·Filed 2001·Application pending·0 cites
- 3545US2003194377A1Therapeutic uses of BPI protein products in cystic fibrosis patientsFiled 2000·Application pending·0 cites
- 3643US6191112B1Human therapeutic uses of BPI protein productsXOMA CORP·Filed 1999·Granted Feb 20, 2001·3 cites·1 claims
- 3743US2010316651A1Cardiovascular related uses of il-1beta antibodies and binding fragments thereofXOMA TECHNOLOGY LTD·Filed 2010·Application pending·0 cites
- 3840US6242418B1Therapeutic uses of BPI protein products for human meningococcemiaXOMA CORP·Filed 1999·Granted Jun 5, 2001·2 cites·5 claims
- 3937US5945399ATherapeutic uses of BPI protein products in humans with hemorrhage due to traumaXOMA CORP·Filed 1997·Granted Aug 31, 1999·5 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Patrick J. Scannon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →